CSL
ASX:CSLAustralian JobsGlobal biotech. Plasma therapies, vaccines, and gene therapy.
CSL operates in 35+ countries but these reflect genuine global manufacturing and plasma collection operations, not cost-driven offshoring. No evidence of IT, call centre, or back-office offshoring to low-cost countries.
Financial Context
Market Cap
$130.0B
Revenue
$21.8B
Net Profit
$3.2B
Financial data: FY2024.
Other Healthcare Companies That Offshore
Other companies in healthcare with reported offshore operations.
What Public Sources Say
All information below is sourced from publicly available documents and reporting. Excerpts are direct quotes. Click source links to verify.
Additional Sources
This profile is based on publicly available information at the time of publication. It may not reflect current operations and should not be treated as a complete picture. We publish what we can verify — not everything that exists.
Is something wrong or missing? Submit a correction. We welcome input from companies, employees, and researchers.